Covance has the expertise to help you overcome the unique challenges of late-phase clinical development. Find out how Covance supports new indications, value communication, adherence strategies, long-term safety and efficacy by reviewing our brochure.

1. GENERATING AND
COMMUNICATING EVIDENCE
TO ENHANCE PATIENT CARE
AND PRODUCT VALUE
 Access & Strategy
 Evidence Generation
 Value Communication
 Patient Support
 Field Services
 Phase IV Solutions Phase IV Solutions

2. FORWARD-THINKING
SOLUTIONS FOR
POST-MARKETING AND
REAL-WORLD STUDIES
Covance has the expertise to help
you overcome the unique challenges
of late-phase clinical development.
Late-phase products often have complex needs,
requiring clinical research informed by marketing
demands. Research at this phase supports new
indications, value communication, adherence
strategies, long-term safety and efficacy and more.
Covance has comprehensive experience in every
facet of late-phase research.
ff We have the critical resources to reach your goals,
including unique access to extensive patient
data through our relationship with our parent
company, LabCorp, the world’s leading healthcare
diagnostic company.
ff We work with you to define strategy, develop and
synthesize evidence and communicate value.
ff Our flexible solutions and multidisciplinary
approach address your post-approval strategy,
establish and extend the value of your product
and defend your market position.
ff Our goal is to maximize the value of your product
throughout its lifecycle.

3. Our dedicated team can support you through the full range of late-phase research:
 Interventional Phase IIIb/IV clinical trials
 Non-interventional Phase IV studies
 Real-world evidence
 Publication planning
Research in the late phase requires a flexible, project-specific approach
that may involve any combination of the following services:
 Strategy and consulting
 Commercial strategy
 HEOR
 Scientific and strategic input
 Regulatory
 Site identification and management
 Project management
 Natural history studies
 Registries
 Outcomes research
 Pharmacovigilance
 Data management/biostatistics
• Access to extensive proprietary data sets
 Medical writing
 Patient safety
 Mobile health solutions
 Value communication
Cost-Effective,
Streamlined Solutions
that Demonstrate
Product Value
Marketing
Real World
Evidence
Medical
Affairs
Health
Economic
Outcomes
Research
Research
and
Development
Clinical
Development
Observational
Research
Epidemiology
Safety/PV
CUSTOMIZED SOLUTIONS TAILORED
TO YOUR BUSINESS NEEDS
Because every late-stage challenge is unique, every Phase IV Solutions project starts with
a comprehensive assessment of your needs and priorities. We assemble the experienced
team and design the dedicated organizational model you need to achieve your business
objectives.

4. Market Access & Phase IV Solutions
Experience Forward Thinking
Covance has the experience and forward thinking to help you
optimize the clinical and commercial value of your brand. We form
relationships built on trust and expertise. We stop to listen and
fully appreciate your unique needs. We understand the markets in
which you compete and we have mastered the skills essential to
help you achieve your goals. From access, to evidence generation,
to communicating value stories to patient and field support, we
harness our collective experience to customize forward-thinking
solutions.
www.covance.com/marketaccess
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory
Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the
marketing name for Covance Inc. and its subsidiaries around the world.
The Americas +1.888.COVANCE (+1.888.268.2623) +1.609.452.4440
Europe / Africa +00.800.2682.2682 +44.1423.500888
Asia Pacific +800.6568.3000 +65.6.5686588
© Copyright 2018 Covance Inc. BROCMA011-0418